Study of Sexual Functioning Determinants in Breast Cancer Survivors

Speer, Justine J.; Hillenberg, Bruce; Sugrue, Dennis P.; Blacker, C. P.; Kresge, Cynthia; Decker, Veronica; Zakalik, Dana; Decker, David A.

doi:10.1111/j.1075-122x.2005.00131.x

Cited by 180 publications

(175 citation statements)

References 28 publications

Supporting

Mentioning

122

Contrasting

Unclassified

Order By: Relevance

“…Nowadays, among many questionnaires, the FSFI is commonly used for the assessment of sexual functions and the SF-36 is generally used to evaluate the psychological, physical and mental functions. 12,[20][21][22][23] We too used the FSFI and the SF-36 questionnaires in our study. Making a decision regarding sterilization is difficult for both men and women, as it means terminating fertility.…”

Section: Discussionmentioning

confidence: 99%

Sexual functions and quality of life in women with tubal sterilization

et al. 2010

View full text Add to dashboard Cite

The aim of this study was to evaluate the sexual functions and quality of life of women who have undergone tubal sterilization after tubal surgery. In all, 90 active premenopausal women, who had undergone tubal sterilization at least 1 year ago and been admitted to four different hospitals, were included in the study group. A total of 100 women at a similar age range, admitted to the same four hospitals for routine health controls, were included in the control group. To obtain sexual function assessments, the patients were asked to fill out Female Sexual Function Index (FSFI) questionnaire. The participants were also asked to fill out Medical Outcomes Study Short Form (SF-36) questionnaire. All values were found to be lower in the tubal sterilization (TS) group and the differences between groups were statistically significant in domain except for pain and lubrication. Similarly, in the analysis of SF-36 scores, there were differences in comparison with the TS group in all domains. In the evaluation of the relationship of FSFI with educational level in the TS group, it was found that, while the educational level increased, all domain scores also increased, and this increase was statistically significant in all domains except pain. The termination of fertility, which is one of the important abilities of women, with tubal sterilization, may be a risk factor for female sexual dysfunction in people with low educational levels.

show abstract

Section: Discussionmentioning

confidence: 99%

Sexual functions and quality of life in women with tubal sterilization

et al. 2010

View full text Add to dashboard Cite

show abstract

“…Beside fatigue, other physical symptoms associated with depression were pain (Vahdaninia et al, 2010), sleep disturbance (Bower et al, 2011) and low sexual desire (Speer et al, 2005). Other illness-related factors included reduced chance of survival (Watson et al, 1999), increased cortisol level at 2100 hours (Hsiao et al, 2012) and high co-morbidity index (Chen et al, 2009).…”

Section: Factors Associated With Depressionmentioning

confidence: 99%

Prevalence of Depression in Breast Cancer Survivors: a Systematic Review of Observational Studies

Zainal¹,

Nik-Jaafar²,

Baharudin³

et al. 2013

Asian Pacific Journal of Cancer Prevention

166

119

View full text Add to dashboard Cite

Background: Depression is common in breast cancer patients. The aim of this paper was to make a systematic review of its prevalence and associated factors oin breast cancer survivors. Materials and Methods: An extensive systematic electronic review (PUBMED, CINAHL, PsyINFO and Ovid) and handsearch were carried out to retrieve published articles up to November 2012, using Depression OR Dysthymia AND (Cancer OR Tumor OR Neoplasms as the keywords. Information about the design of the studies, measuring scale, characteristics of the participants, prevalence of depression and its associated factors from the included studies were extracted and summarized. Results: We identified 32 eligible studies that recruited 10,826 breast cancer survivors. Most were cross-sectional or prospective designed. The most frequent instrument used to screen depression was the Center for Epidemiological Studies for Depression (CES-D, n=11 studies) followed by the Beck Depression Inventory (BDI, n=6 studies) and the Hospital Anxiety and Depression Scale (HADS, n=6 studies). CES-D returned about similar prevalence of depression (median=22%, range=13-56%) with BDI (median=22%, range=17-48%) but higher than HADS (median=10%, range=1-22%). Depression was associated with several socio-demographic variables, cancer-related factors, treatment-related factors, subject psychological factors, lifestyle factors, social support and quality of life. Conclusions: Breast cancer survivors are at risk for depression so that detection of associated factors is important in clinical practice.

show abstract

“…8 Medications used to treat emotional stress, such as antidepressants and anxiolytics, modulate the dopaminergic and serotonergic pathways in the central nervous system and increase the levels of prolactin, all of which are involved in sexual response. [7][8][9][10] Breast cancer surgery can result in scarring, asymmetry, sensory changes, and a negative self-image. Approximately 33% of women undergoing mastectomy for breast cancer report that the procedure had a negative impact on their sexual relation with their partners.…”

mentioning

confidence: 99%

Sexual function, anxiety and depression in women with benign breast disease. A case-control study

Fairbanks

Andres

Caldeira

et al. 2017

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

Summary Introduction: Sexual dysfunction is highly prevalent, affecting 40% of the female population. The incidence of such dysfunction is known to be higher among women with malignant breast disease and in patients with depression or anxiety. However, there are few data regarding the prevalence of sexual dysfunction among women with benign breast disease (BBD). Objective: To evaluate the incidence of sexual dysfunction, depression and anxiety among women with BBD, in comparison with that observed for healthy women. Method: We evaluated the incidence of sexual dysfunction in 60 patients with benign breast disease (fibroadenomas, breast cysts, breast pain and phyllodes tumor) and 69 healthy women (control group). Participants completed the Sexual Quotient Questionnaire for Females (SQQ-F), the Beck Depression Inventory and the Beck Anxiety Inventory. Statistical analysis revealed that depression and anxiety were comparable between BBD and control groups (10.3 vs. 20.3% and 38.7 vs. 34.3%, respectively, p>0.05). The mean SQQ-F score (65.6±22.7 vs. 70.1±16.8; p>0.05) and sexual dysfunction (33.3 vs. 25.4%; p=0.324) were similar between BBD and control groups. Conclusion: We found no differences between women with BBD and healthy women in terms of the incidence of sexual dysfunction, anxiety and depression. Nevertheless, given the high prevalence of this condition, it is important to assess sexual quality of life, as well as overall quality of life, in women with BBD.

show abstract

Study of Sexual Functioning Determinants in Breast Cancer Survivors

Cited by 180 publications

References 28 publications

Sexual functions and quality of life in women with tubal sterilization

Sexual functions and quality of life in women with tubal sterilization

Prevalence of Depression in Breast Cancer Survivors: a Systematic Review of Observational Studies

Sexual function, anxiety and depression in women with benign breast disease. A case-control study

Contact Info

Product

Resources

About